Insmed Inc INSM:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 10/05/22 EDT
23.02quote price arrow up+23.02 (UNCH)
Volume
12,117
Close
23.02quote price arrow down-0.13 (-0.56%)
Volume
563,202
52 week range
16.41 - 34.44
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close23.02
  • 52 Week High34.44
  • 52 Week High Date11/04/21
  • 52 Week Low16.41
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap2.762B
  • Shares Out119.98M
  • 10 Day Average Volume0.95M
  • Dividend-
  • Dividend Yield-
  • Beta1.72
  • YTD % Change-15.49

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close23.02
  • 52 Week High34.44
  • 52 Week High Date11/04/21
  • 52 Week Low16.41
  • 52 Week Low Date05/12/22
  • Market Cap2.762B
  • Shares Out119.98M
  • 10 Day Average Volume0.95M
  • Dividend-
  • Dividend Yield-
  • Beta1.72
  • YTD % Change-15.49

RATIOS/PROFITABILITY

  • EPS (TTM)-3.51
  • P/E (TTM)-6.56
  • Fwd P/E (NTM)-6.58
  • EBITDA (TTM)-384.193M
  • ROE (TTM)-144.61%
  • Revenue (TTM)221.21M
  • Gross Margin (TTM)76.47%
  • Net Margin (TTM)-188.04%
  • Debt To Equity (MRQ)1,824.83%

EVENTS

  • Earnings Date10/26/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Insmed Inc

 

Content From Our Affiliates

Profile

MORE
Insmed Incorporated is a biopharmaceutical company engaged in providing ARIKAYCE (amikacin liposome inhalation suspension) product, which is used for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. Its clinical-stage pipeline includes brensocatib and treprostinil palmitil inhalation powder (TPIP). Brensocatib is a small molecule, oral, reversible...
William Lewis
Chairman of the Board, President, Chief Executive Officer
Roger Adsett
Chief Operating Officer
Sara Bonstein
Chief Financial Officer
Address
700 Us Highway 202/206
Bridgewater, NJ
08807
United States

Top Peers

SYMBOLLASTCHG%CHG
BCRX
BioCryst Pharmaceuticals Inc
14.14+0.07+0.50%
PRTA
Prothena Corporation PLC
58.11+0.66+1.15%
ARVN
Arvinas Inc
44.78+0.64+1.45%
FOLD
Amicus Therapeutics Inc
10.85-0.06-0.55%
RARE
Ultragenyx Pharmaceutical Inc
40.54-2.12-4.97%